Company intelligence / Profile preview
AnnJi Pharmaceutical Co., Ltd.
Taiwanajpharm.com ↗
- Ownership
- Public · 7754
- Development stage
- Other
01
Overview
AnnJi has demonstrated promising early clinical results. AJ101 showed significant reduction in inflammatory acne lesions in global Phase 1/2 studies. AJ201 is in a first-in-patient Phase 1/2a trial for Kennedy’s Disease/SBMA, with orphan drug designations granted by the FDA and EMA. Other assets are advancing toward or entering clinical trials for CIPN and IPF/fibrosis.
- Therapeutic areas
- DermatologyPulmonologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Avenue Therapeutics – licensing agreement for development/commercialization of AJ201 in Kennedy’s Disease/SBMA; includes equity stake, milestone payments up to $250M plus royalties. Manufacturing rights retained by AnnJi.
04
Financials
- Market cap
- $186.4M
- Total revenue
- $230.5K
- Enterprise value
- $173.8M
Beyond the preview
Go deeper on AnnJi Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AnnJi Pharmaceutical Co., Ltd..